Metropolitan Life Insurance Company (MetLife)’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-52,890
| Closed | -$5.14M | – | 1200 |
|
|
2024
Q1 | $5.14M | Sell |
52,890
-760
| -1% | -$66.9K | 0.22% | 78 |
|
|
2023
Q4 | $4.2M | Sell |
53,650
-1,510
| -3% | -$103K | 0.2% | 92 |
|
|
2023
Q3 | $3.46M | Sell |
55,160
-3,390
| -6% | -$223K | 0.18% | 102 |
|
|
2023
Q2 | $3.76M | Sell |
58,550
-1,810
| -3% | -$102K | 0.18% | 100 |
|
|
2023
Q1 | $3.2M | Sell |
60,360
-15,330
| -20% | -$752K | 0.16% | 115 |
|
|
2022
Q4 | $3.18M | Sell |
75,690
-2,970
| -4% | -$124K | 0.14% | 142 |
|
|
2022
Q3 | $2.88M | Sell |
78,660
-1,980
| -2% | -$88.1K | 0.14% | 145 |
|
|
2022
Q2 | $3.44M | Sell |
80,640
-2,520
| -3% | -$120K | 0.15% | 134 |
|
|
2022
Q1 | $4.47M | Sell |
83,160
-140,430
| -63% | -$8.17M | 0.16% | 121 |
|
|
2021
Q4 | $16.1M | Sell |
223,590
-8,190
| -4% | -$513K | 0.22% | 75 |
|
|
2021
Q3 | $13.2M | Sell |
231,780
-7,810
| -3% | -$475K | 0.19% | 93 |
|
|
2021
Q2 | $15.6M | Sell |
239,590
-8,360
| -3% | -$528K | 0.22% | 83 |
|
|
2021
Q1 | $14.8M | Sell |
247,950
-17,300
| -7% | -$943K | 0.22% | 80 |
|
|
2020
Q4 | $12.5M | Sell |
265,250
-12,290
| -4% | -$517K | 0.19% | 88 |
|
|
2020
Q3 | $9.21M | Sell |
277,540
-10,720
| -4% | -$369K | 0.16% | 109 |
|
|
2020
Q2 | $9.32M | Buy |
288,260
+14,880
| +5% | +$406K | 0.17% | 107 |
|
|
2020
Q1 | $6.56M | Sell |
273,380
-3,640
| -1% | -$105K | 0.13% | 143 |
|
|
2019
Q4 | $8.1M | Sell |
277,020
-4,740
| -2% | -$126K | 0.13% | 141 |
|
|
2019
Q3 | $6.51M | Sell |
281,760
-20,830
| -7% | -$437K | 0.11% | 160 |
|
|
2019
Q2 | $5.68M | Buy |
302,590
+8,540
| +3% | +$162K | 0.1% | 186 |
|
|
2019
Q1 | $5.26M | Sell |
294,050
-12,730
| -4% | -$212K | 0.1% | 185 |
|
|
2018
Q4 | $4.18M | Sell |
306,780
-1,790
| -0.6% | -$25.7K | 0.08% | 200 |
|
|
2018
Q3 | $4.68M | Sell |
308,570
-20,090
| -6% | -$343K | 0.08% | 210 |
|
|
2018
Q2 | $5.68M | Buy |
328,660
+4,630
| +1% | +$89.2K | 0.09% | 189 |
|
|
2018
Q1 | $6.58M | Buy |
324,030
+3,920
| +1% | +$77.6K | 0.09% | 174 |
|
|
2017
Q4 | $5.89M | Sell |
320,110
-519,280
| -62% | -$10.2M | 0.08% | 186 |
|
|
2017
Q3 | $15.5M | Sell |
839,390
-5,550
| -0.7% | -$90.1K | 0.1% | 184 |
|
|
2017
Q2 | $11.9M | Sell |
844,940
-7,200
| -0.8% | -$106K | 0.08% | 229 |
|
|
2017
Q1 | $10.9M | Sell |
852,140
-11,850
| -1% | -$139K | 0.08% | 244 |
|
|
2016
Q4 | $9.13M | Sell |
863,990
-11,290
| -1% | -$115K | 0.07% | 278 |
|
|
2016
Q3 | $8.29M | Sell |
875,280
-6,820
| -0.8% | -$62.1K | 0.06% | 297 |
|
|
2016
Q2 | $7.42M | Buy |
882,100
+2,080
| +0.2% | +$16.7K | 0.06% | 332 |
|
|
2016
Q1 | $7.27M | Sell |
880,020
-9,630
| -1% | -$70K | 0.06% | 331 |
|
|
2015
Q4 | $7.07M | Sell |
889,650
-11,010
| -1% | -$82.8K | 0.05% | 330 |
|
|
2015
Q3 | $5.88M | Sell |
900,660
-16,510
| -2% | -$121K | 0.04% | 424 |
|
|
2015
Q2 | $7.46M | Buy |
917,170
+26,800
| +3% | +$210K | 0.05% | 358 |
|
|
2015
Q1 | $6.25M | Sell |
890,370
-9,830
| -1% | -$77.7K | 0.05% | 423 |
|
|
2014
Q4 | $7.14M | Sell |
900,200
-33,910
| -4% | -$263K | 0.05% | 368 |
|
|
2014
Q3 | $6.98M | Sell |
934,110
-14,300
| -2% | -$102K | 0.05% | 364 |
|
|
2014
Q2 | $6.41M | Sell |
948,410
-44,980
| -5% | -$269K | 0.04% | 418 |
|
|
2014
Q1 | $5.46M | Sell |
993,390
-15,960
| -2% | -$84.8K | 0.04% | 491 |
|
|
2013
Q4 | $5.5M | Sell |
1,009,350
-22,680
| -2% | -$119K | 0.04% | 474 |
|
|
2013
Q3 | $5.28M | Sell |
1,032,030
-3,550
| -0.3% | -$17.4K | 0.04% | 464 |
|
|
2013
Q2 | $4.59M | Buy |
+1,035,580
| New | +$4.68M | 0.04% | 482 |
|
Other funds holding LRCX
Metropolitan Life Insurance Company (MetLife)'s LRCX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Lam Research (LRCX) in Q2 2024, closing a stake of 52,890 shares — an estimated $5.14M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in LRCX in Q2 2013 and held it in 44 quarters. The position peaked at $16.1M in Q4 2021. 1,791 funds tracked by Wall St. Rank hold LRCX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Lam Research position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 52,890 Lam Research shares in Q2 2024, an estimated $5.14M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Lam Research in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Lam Research position peaked at $16.1M in Q4 2021.
- 1,791 funds tracked by Wall St. Rank held Lam Research as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.